New CEO in place for Cempra, Melinta combination

Following their announcement of plans to merge, Chapel Hill-based Cempra (Nasdaq: CEMP) and New Haven, Connecticut-based Melinta Therapeutics has selected Dan Wechsler to be president and CEO – as well as a board member – of the combined company.  The merger is expected to close later this year. Wechsler will join the combined company from New York-based private equity firm Welsh, Carson, Anderson& Stowe, which he joined last year after serving as president and CEO of Smile Brands before …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news